Results 21 to 30 of about 206,766 (202)

Vaccination Safety Update [PDF]

open access: yesDeutsches Ärzteblatt international, 2008
In Germany, a large number of biased reports against vaccination have recently been published in all of the news media, and particularly on the internet. This paper discusses the safety profile of modern vaccines and their continuous surveillance and shows why the current criticism of vaccination on safety grounds is unjustified.The authors have ...
Burkhard, Schneeweiss   +2 more
openaire   +2 more sources

The safety of vaccines

open access: yesDrug Discovery Today, 2004
Vaccines have had a considerable impact on society by eliminating the threat from several infectious diseases. Although vaccines have generally proven to be safe, safety issues have arisen that have resulted in some members of the public having a poor perception of vaccines.
O'Hagan, Derek T., Rappuoli, Rino
openaire   +2 more sources

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. [PDF]

open access: yes, 2008
BACKGROUND: The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI).
Machera, Francisca   +23 more
core   +1 more source

Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19

open access: yes, 2023
Creating an effective and safe vaccine is critical to fighting the coronavirus infection successfully. Several types of COVID-19 vaccines exist, including inactivated, live attenuated, recombinant, synthetic peptide, virus-like particle-based, DNA and ...
Aziz Nakhanov   +22 more
core   +1 more source

Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review [PDF]

open access: yesOsong Public Health and Research Perspectives
This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 ...
Seungeun Ryoo   +6 more
doaj   +1 more source

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines

open access: yesnpj Vaccines, 2022
SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373), an mRNA- (Comirnaty), and
Michael Karbiener   +6 more
doaj   +1 more source

COVID-19 vaccine safety

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2021
The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic.
Nataniel Aldo Chaparro Mérida   +2 more
doaj   +1 more source

Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline

open access: yesFrontiers in Public Health, 2022
Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Victoria's vaccine safety service for reporting adverse events following immunisation (AEFI), has provided integrated spontaneous surveillance and clinical services for ...
Ingrid Laemmle-Ruff   +14 more
doaj   +1 more source

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. [PDF]

open access: yes, 2009
BACKGROUND: Development and deployment of an effective malaria vaccine would complement existing malaria control measures. A blood stage malaria vaccine candidate, Merozoite Surface Protein-3 (MSP3), produced as a long synthetic peptide, has been shown ...
Gesase Samwel   +44 more
core   +1 more source

A social media intervention for communicating vaccine safety in low- and middle-income countries: protocol for a pilot study

open access: yesFrontiers in Public Health, 2023
Vaccine safety is a concern that continues to drive hesitancy and refusal in populations in low-and-middle income countries (LMICs). Communicating about vaccine safety is a strategy that can successfully change personal and community perceptions and ...
Lucie Marisa Bucci   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy